+52.1%
GSK vs PLTD
-77.3%
+129.4%
-18.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | PLTD | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.7% | +2.3% | -5.0% | -2.7% |
| 7D | -4.2% | +4.5% | -8.7% | -4.3% |
| 30D | -7.5% | -0.7% | -6.8% | -7.5% |
| 3M | -3.3% | -31.0% | +27.8% | -2.6% |
| 6M | -9.3% | -24.8% | +15.5% | -8.9% |
| YTD | +1.6% | -18.6% | +20.2% | +2.1% |
| 1Y | +25.5% | -31.8% | +57.3% | +26.3% |
| All | +52.1% | -77.3% | +129.4% | +54.2% |
Cumulative growth
Daily Returns
Daily percentage return beside PLTD.
Daily Out/Under-Performance
Portfolio return minus PLTD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PLTD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded PLTD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling